Preskorn, Sheldon H.

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

Fedgchin, M., Trivedi, M., Daly, E. J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 606

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors: An Overview with Emphasis on Pharmacokinetics and Effects on Oxidative Drug Metabolism

Preskorn, S. H. (1997) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 370

Evidence of the dual mechanisms of action of venlafaxine

Harvey, A. T., Rudolph, R. L., & Preskorn, S. H. (2000) · Archives of General Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 302

Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent

PRESKORN, S., MACALUSO, M., MEHRA, D. V., ZAMMIT, G., MOSKAL, J. R., & BURCH, R. M. (2015) · Journal of Psychiatric Practice

Treatment of Major DepressionTryptophan and brain disorders

Cited by 193

Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression

Williamson, D. J., Gogate, J. P., Sliwa, J. K. K., Manera, L. S., Preskorn, S. H., Winokur, A., Starr, H. L., & Daly, E. J. (2022) · The Journal of Clinical Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 15

General Principles of Pharmacokinetics

Preskorn, S. H., & Catterson, M. L. (2004) · Handbook of Experimental Pharmacology

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 14

The role of proof of concept (POC) studies in drug development using the EVP-6124 POC study as an example.

PRESKORN, S. H. (2014) · Journal of Psychiatric Practice

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 13

Declining Differences in Response Rates with Antidepressants versus Placebo: A Modest Proposal for Another Contributing Cause

PRESKORN, S. H. (2013) · Journal of Psychiatric Practice

Treatment of Major DepressionPain Management and Placebo Effect

Cited by 12